Skip to content
Screener

Staar Surgical STAA Total Liabilities & Equity

Total Liabilities & Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$24.5B-7.3%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$66.22M-9.2%
IAR
Integra LifeSciencesIART
$3.56B-2.8%
Schering-Plough logo
Schering-PloughSGP
$258.39M
Glaukos logo
GlaukosGKOS
$920.52M-6.7%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.25B-7.5%
Enterprise value$1.16B-5.7%
P/S4.3×-1.7×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemApril 3, 2026January 2, 2026
Stockholders’ equity:
Common stock, $0.01 par value; 60,000 shares authorized: 50,156 shares issued and 49,780 shares outstanding at April 3, 2026 and 49,779 shares issued and 49,403 outstanding at January 2, 2026502498
Additional paid-in capital507,921504,682
Treasury stock, 376 and 376 shares at April 3, 2026 and January 2, 2026, respectively(6,461)(6,461)
Accumulated other comprehensive loss(6,778)(6,511)
Accumulated deficit(142,818)(148,024)
Total stockholders’ equity352,366344,184
Total liabilities and stockholders’ equity$451,118$451,678

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's total liabilities & equity?
Staar Surgical (STAA) reported total liabilities & equity of $451.12M in Q1 2026.
How has Staar Surgical's total liabilities & equity changed year-over-year?
Staar Surgical's total liabilities & equity decreased by 1.4% year-over-year, from $457.36M to $451.12M.
What is the long-term trend for Staar Surgical's total liabilities & equity?
Over 5 years (2020 to 2025), Staar Surgical's total liabilities & equity has grown at a 11.9% compound annual growth rate (CAGR), from $257.42M to $451.68M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Staar Surgical's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude